Outcome of Lateral Pancreaticojejunostomy in the Management of Chronic Pancreatitis with Nondilated Pancreatic Ducts

Gloria A. Rios, David B. Adams, Khay Guan Yeoh, Paul R. Tarnasky, John T Cunningham, Robert H. Hawes

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Lateral pancreaticojejunostomy has demonstrated variable success in the management of chronic pancreatitis associated with ductal dilation, but its role in patients with nondilated ducts is poorly defined. The aim of this study was to assess the outcome of lateral pancreaticojejunostomy in chronic pancreatitis with nondilated pancreatic ducts. The records of all patients who underwent lateral pancreaticojejunostomy with a pancreatic duct measuring less than 7 mm in diameter were reviewed. Seventeen patients underwent lateral pancreaticojejunostomy for chronic pancreatitis and intractable pain between 1995 and 1996. Endoscopic retrograde cholangiopancreatography demonstrated features of chronic pancreatitis that were mild in seven patients, moderate in five, and severe in four. Postoperative complications occurred in two patients (11.7%). There were no deaths. Mean length of follow-up was 10.3 months (range 3 to 16 months). Rehospitalization for recurrent pancreatitis or pain was necessary in 59% of patients. Emergency room visits were reported by 76%. Narcotic use continued in 88%, with 76% of the patients reporting their pain as the same or worse than before the operation, and 65% continuing to view their health status as poor. In chronic pancreatitis patients with a nondilated pancreatic duct, lateral pancreaticojejunostomy appears to be of little benefit with respect to pain relief, subsequent hospitalization, continued narcotic use, or overall health status.

Original languageEnglish (US)
Pages (from-to)223-229
Number of pages7
JournalJournal of Gastrointestinal Surgery
Volume2
Issue number3
StatePublished - May 1998
Externally publishedYes

Fingerprint

Pancreaticojejunostomy
Pancreatic Ducts
Chronic Pancreatitis
Narcotics
Pain
Health Status
Intractable Pain
Endoscopic Retrograde Cholangiopancreatography
Chronic Pain
Pancreatitis
Hospital Emergency Service
Dilatation
Hospitalization

ASJC Scopus subject areas

  • Surgery

Cite this

Outcome of Lateral Pancreaticojejunostomy in the Management of Chronic Pancreatitis with Nondilated Pancreatic Ducts. / Rios, Gloria A.; Adams, David B.; Yeoh, Khay Guan; Tarnasky, Paul R.; Cunningham, John T; Hawes, Robert H.

In: Journal of Gastrointestinal Surgery, Vol. 2, No. 3, 05.1998, p. 223-229.

Research output: Contribution to journalArticle

Rios, Gloria A. ; Adams, David B. ; Yeoh, Khay Guan ; Tarnasky, Paul R. ; Cunningham, John T ; Hawes, Robert H. / Outcome of Lateral Pancreaticojejunostomy in the Management of Chronic Pancreatitis with Nondilated Pancreatic Ducts. In: Journal of Gastrointestinal Surgery. 1998 ; Vol. 2, No. 3. pp. 223-229.
@article{2ff387404efc45989b4411010dbf8615,
title = "Outcome of Lateral Pancreaticojejunostomy in the Management of Chronic Pancreatitis with Nondilated Pancreatic Ducts",
abstract = "Lateral pancreaticojejunostomy has demonstrated variable success in the management of chronic pancreatitis associated with ductal dilation, but its role in patients with nondilated ducts is poorly defined. The aim of this study was to assess the outcome of lateral pancreaticojejunostomy in chronic pancreatitis with nondilated pancreatic ducts. The records of all patients who underwent lateral pancreaticojejunostomy with a pancreatic duct measuring less than 7 mm in diameter were reviewed. Seventeen patients underwent lateral pancreaticojejunostomy for chronic pancreatitis and intractable pain between 1995 and 1996. Endoscopic retrograde cholangiopancreatography demonstrated features of chronic pancreatitis that were mild in seven patients, moderate in five, and severe in four. Postoperative complications occurred in two patients (11.7{\%}). There were no deaths. Mean length of follow-up was 10.3 months (range 3 to 16 months). Rehospitalization for recurrent pancreatitis or pain was necessary in 59{\%} of patients. Emergency room visits were reported by 76{\%}. Narcotic use continued in 88{\%}, with 76{\%} of the patients reporting their pain as the same or worse than before the operation, and 65{\%} continuing to view their health status as poor. In chronic pancreatitis patients with a nondilated pancreatic duct, lateral pancreaticojejunostomy appears to be of little benefit with respect to pain relief, subsequent hospitalization, continued narcotic use, or overall health status.",
author = "Rios, {Gloria A.} and Adams, {David B.} and Yeoh, {Khay Guan} and Tarnasky, {Paul R.} and Cunningham, {John T} and Hawes, {Robert H.}",
year = "1998",
month = "5",
language = "English (US)",
volume = "2",
pages = "223--229",
journal = "Journal of Gastrointestinal Surgery",
issn = "1091-255X",
publisher = "Springer New York",
number = "3",

}

TY - JOUR

T1 - Outcome of Lateral Pancreaticojejunostomy in the Management of Chronic Pancreatitis with Nondilated Pancreatic Ducts

AU - Rios, Gloria A.

AU - Adams, David B.

AU - Yeoh, Khay Guan

AU - Tarnasky, Paul R.

AU - Cunningham, John T

AU - Hawes, Robert H.

PY - 1998/5

Y1 - 1998/5

N2 - Lateral pancreaticojejunostomy has demonstrated variable success in the management of chronic pancreatitis associated with ductal dilation, but its role in patients with nondilated ducts is poorly defined. The aim of this study was to assess the outcome of lateral pancreaticojejunostomy in chronic pancreatitis with nondilated pancreatic ducts. The records of all patients who underwent lateral pancreaticojejunostomy with a pancreatic duct measuring less than 7 mm in diameter were reviewed. Seventeen patients underwent lateral pancreaticojejunostomy for chronic pancreatitis and intractable pain between 1995 and 1996. Endoscopic retrograde cholangiopancreatography demonstrated features of chronic pancreatitis that were mild in seven patients, moderate in five, and severe in four. Postoperative complications occurred in two patients (11.7%). There were no deaths. Mean length of follow-up was 10.3 months (range 3 to 16 months). Rehospitalization for recurrent pancreatitis or pain was necessary in 59% of patients. Emergency room visits were reported by 76%. Narcotic use continued in 88%, with 76% of the patients reporting their pain as the same or worse than before the operation, and 65% continuing to view their health status as poor. In chronic pancreatitis patients with a nondilated pancreatic duct, lateral pancreaticojejunostomy appears to be of little benefit with respect to pain relief, subsequent hospitalization, continued narcotic use, or overall health status.

AB - Lateral pancreaticojejunostomy has demonstrated variable success in the management of chronic pancreatitis associated with ductal dilation, but its role in patients with nondilated ducts is poorly defined. The aim of this study was to assess the outcome of lateral pancreaticojejunostomy in chronic pancreatitis with nondilated pancreatic ducts. The records of all patients who underwent lateral pancreaticojejunostomy with a pancreatic duct measuring less than 7 mm in diameter were reviewed. Seventeen patients underwent lateral pancreaticojejunostomy for chronic pancreatitis and intractable pain between 1995 and 1996. Endoscopic retrograde cholangiopancreatography demonstrated features of chronic pancreatitis that were mild in seven patients, moderate in five, and severe in four. Postoperative complications occurred in two patients (11.7%). There were no deaths. Mean length of follow-up was 10.3 months (range 3 to 16 months). Rehospitalization for recurrent pancreatitis or pain was necessary in 59% of patients. Emergency room visits were reported by 76%. Narcotic use continued in 88%, with 76% of the patients reporting their pain as the same or worse than before the operation, and 65% continuing to view their health status as poor. In chronic pancreatitis patients with a nondilated pancreatic duct, lateral pancreaticojejunostomy appears to be of little benefit with respect to pain relief, subsequent hospitalization, continued narcotic use, or overall health status.

UR - http://www.scopus.com/inward/record.url?scp=0032057482&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032057482&partnerID=8YFLogxK

M3 - Article

C2 - 9841978

AN - SCOPUS:0032057482

VL - 2

SP - 223

EP - 229

JO - Journal of Gastrointestinal Surgery

JF - Journal of Gastrointestinal Surgery

SN - 1091-255X

IS - 3

ER -